ArticleEuropean urology2023

A Phase 1 Trial of Durvalumab in Combination with Bacillus Calmette-Guerin (BCG) or External Beam Radiation Therapy in Patients with BCG-unresponsive Non-muscle-Invasive Bladder Cancer: The Hoosier Cancer Research Network GU16-243 ADAPT-BLADDER Study.

Noah M Hahn et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.